Salarius Pharmaceuticals SLRX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 1.84 | 101.71 | -0.66 | -1,489 | -1 | |
| 2024Q3 | 1.44 | 103.50 | 0.49 | -1,006 | -1 | |
| 2024Q2 | 2.38 | 103.02 | -2.34 | -1,468 | -1 | |
| 2024Q1 | 4.23 | 103.26 | -3.28 | -1,772 | -2 | |
| 2023Q4 | 5.20 | 110.09 | -0.03 | -971 | -1 | |
| 2023Q3 | 5.26 | 103.64 | -3.10 | -2,532 | -2 | |
| 2023Q2 | 11.92 | 102.42 | -9.77 | -3,971 | -4 | |
| 2023Q1 | 15.28 | 101.50 | -17.84 | -5,421 | -5 | |
| 2022Q4 | 12.24 | 101.68 | -22.00 | -6,478 | -6 | |
| 2022Q3 | 39.00 | 99.76 | -53.68 | -14,488 | -14 | |
| 2022Q2 | 42.00 | 100.08 | -16.96 | -4,758 | -5 | |
| 2022Q1 | 79.62 | 100.10 | -26.40 | -6,117 | -6 | |
| 2021Q4 | 99.12 | 100.95 | -18.48 | -4,145 | -4 | |
| 2021Q3 | 204.00 | 100.24 | -17.28 | -3,747 | -4 | |
| 2021Q2 | 212.00 | 101.37 | -14.00 | -3,117 | -3 | |
| 2021Q1 | 296.00 | 97.51 | -12.00 | -1,805 | -2 | |
| 2020Q4 | 182.00 | 99.60 | -20.00 | -1,757 | -2 | |
| 2020Q3 | 168.78 | 102.63 | -14.00 | -1,759 | -2 | |
| 2020Q2 | 264.00 | 106.68 | -22.00 | -1,901 | -2 | |
| 2020Q1 | 136.14 | 113.72 | -44.00 | -2,370 | -2 |